Court ruling favors GenSpera in U.S. patent disput
Post# of 6702
![Avatar](/images/ProfileImages/2009266216_107_spaceman 200x200.jpg)
![mysa-logo.jpg](http://www.northsachamber.com/wp-content/uploads/2013/07/mysa-logo.jpg)
By Peggy O'Hare
http://www.mysanantonio.com/
http://stockpumpers.blogspot.com/2014/11/cour...in-us.html
SAN ANTONIO — A San Antonio company developing prodrug therapeutics to treat cancer said Thursday that a federal court ruled in its favor in a patent dispute.
![Welcome_to_GenSpera.jpg](http://www.genspera.com/images/Welcome_to_GenSpera.jpg)
GenSpera Inc. said it welcomed the Sept. 12 decision by a U.S. District Court in Maryland, which essentially dismisses Dr. Annastasiah Mhaka's claims that she was wrongly omitted from two of the company's U.S. patents for its lead drug candidate, mipsagargin.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)